BURSTNature, Published online: 12 May 2025; doi:10.1038/d41586-025-01503-3
Results from a phase III clinical trial suggest that taking ubrogepant at the first sign of an oncoming migraine can prevent pre-headache fatigue and light sensitivity.Nature, Published online: 12 May 2025; doi:10.1038/d41586-025-01503-3
Results from a phase III clinical trial suggest that taking ubrogepant at the first sign of an oncoming migraine can prevent pre-headache fatigue and light sensitivity.